| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.273 | 42.137 | 38.245 | 41.084 | 38.231 | 32.767 | 27.562 | 29.724 | 20.719 | 19.755 |
| Total Income - EUR | 42.589 | 44.534 | 41.139 | 43.276 | 40.416 | 33.239 | 27.846 | 29.849 | 20.733 | 19.956 |
| Total Expenses - EUR | 40.976 | 43.082 | 41.093 | 45.913 | 40.308 | 32.217 | 26.832 | 27.663 | 20.490 | 19.387 |
| Gross Profit/Loss - EUR | 1.613 | 1.451 | 45 | -2.637 | 109 | 1.022 | 1.014 | 2.186 | 243 | 569 |
| Net Profit/Loss - EUR | 335 | 144 | 34 | -3.479 | -1.064 | 109 | 179 | 1.433 | 205 | 461 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Midoris Medfarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.447 | 568 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 27.460 | 28.493 | 30.148 | 28.719 | 28.491 | 20.842 | 18.924 | 14.427 | 10.691 | 8.824 |
| Inventories | 20.410 | 22.282 | 23.462 | 21.028 | 16.819 | 13.975 | 13.399 | 9.992 | 6.428 | 3.820 |
| Receivables | 6.722 | 5.573 | 5.964 | 5.885 | 5.409 | 4.931 | 4.718 | 3.812 | 2.673 | 1.564 |
| Cash | 329 | 638 | 723 | 1.806 | 6.262 | 1.936 | 807 | 622 | 1.590 | 3.440 |
| Shareholders Funds | -131 | 14 | 9.899 | 6.238 | 5.053 | 5.066 | 5.133 | 6.582 | 6.767 | 7.190 |
| Social Capital | 45 | 45 | 9.895 | 9.713 | 9.525 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | 27.591 | 28.479 | 21.697 | 23.049 | 23.438 | 15.776 | 13.791 | 7.845 | 3.924 | 1.634 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Midoris Medfarm S.r.l.